New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 25, 2013
12:04 EDTQIHU, INFI, BMRN, DKS, CWHOptions with decreasing implied volatility: INFI CWH BMRN QIHU DKS
News For INFI;CWH;BMRN;QIHU;DKS From The Last 14 Days
Check below for free stories on INFI;CWH;BMRN;QIHU;DKS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 22, 2014
10:00 EDTCWHOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: CommonWealth REIT (CWH) downgraded to Sell from Hold at Stifel... Del Frisco's (DFRG) downgraded to Market Perform from Outperform at Raymond James... Deutsche Bank (DB) downgraded to Neutral from Buy at UBS... Diageo (DEO) downgraded to Market Perform from Outperform at Raymond James... Eni SpA (E) downgraded to Neutral from Buy at UBS... Fidelity & Guaranty Life (FGL) downgraded to Neutral from Outperform at Credit Suisse... Frontier Communications (FTR) downgraded to Hold from Buy at Gabelli... QEP Resources (QEP) downgraded to Equalweight from Overweight at Barclays... Rogers Communications (RCI) downgraded to Sell from Hold at Canaccord... Rush Enterprises (RUSHA) downgraded to Underperform from Buy at BofA/Merrill... TSMC (TSM) downgraded to Neutral from Overweight at HSBC... Valero (VLO) downgraded to Neutral from Buy at BofA/Merrill... Wisconsin Energy (WEC) downgraded to Fair Value from Buy at CRT Capital... Zillow (Z) downgraded to Fair Value from Buy at CRT Capital... Zions Bancorp (ZION) downgraded to Equal Weight from Overweight at Evercore.
07:32 EDTCWHCommonWealth REIT downgraded to Sell from Hold at Stifel
Subscribe for More Information
06:44 EDTCWHCommonWealth REIT downgraded to Sell from Hold at Stifel
Subscribe for More Information
April 17, 2014
17:02 EDTBMRNCatalyst Pharmaceutical, BioMarin in amended license agreement
Catalyst Pharmaceutical (CPRX) disclosed in a regulatory filing that on April 15, effective as of April 8, the company and BioMarin Pharmaceutical (BMRN) entered into Amendment No. 1 to License Agreement, amending in certain respects the License Agreement, dated October 26, 2012, between the company and BioMarin. The company intends to submit a FOIA Confidential Treatment Request to the SEC pursuant to Rule 24b-2 under the SEC Act of 1934, as amended, requesting that it be permitted to redact certain portions of the Amendment. The omitted material will be included in the request for confidential treatment.
April 15, 2014
10:29 EDTCWHOptions with increasing implied volatility: YOKU CWH BEAM
Subscribe for More Information
April 14, 2014
16:58 EDTCWHCommonWealth REIT entered into forbearance agreements
Subscribe for More Information
08:22 EDTBMRNBioMarin says FDA extends Kuvan market exclusivity by six months
Subscribe for More Information
05:53 EDTCWHStocks with implied volatility movement; SDS CWH
Subscribe for More Information
April 9, 2014
17:25 EDTINFIPoint72 Asset lowers passive stake in Infinity Pharmaceuticals to 7.1% from 7.5%
Subscribe for More Information
09:20 EDTDKSBofA/Merrill's retail analysts hold an analyst/industry conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use